Four Models of Telephone Support for Stimulant Recovery

NCT00744068 | Completed DMC

• 2 other identifiers: R01DA018208-01A1R01DA018208
• Study Type: interventional
• Target: 302
• Locations: 1 country
• Sites: 6

Brief Summary

The overall objective of this research is to develop and refine empirically supported continuing care interventions that promote healthy behavior and sustained abstinence from illicit drug use.

Conditions

Drug Addiction

Keywords

Stimulant; Drug treatment; Continuing care; Telephone support; Aftercare

Outcome Measures

Primary Outcomes (5)

• Urinalyses

  At 3 months and 12 months

• Breathalyzer tests

  At 3 months and 12 months

• Self-report of drug or alcohol use

  At 3 months and 12 months

• Amount of Treatment Activities

  At 3 months and 12 months

• Length of Treatment Episode

  At 3 months and 12 months

Secondary Outcomes (4)

• Addiction Severity Index (ASI)

  At 3 months and 12 months

• HIV Risk-taking Behavior Scale

  At 3 months and 12 months

• Concurrent Psychosocial Treatments

  At 3 months and 12 months

• Drug Avoidance Activities (DAA) Survey

  At 3 months and 12 months

Study Arms (5)

1

EXPERIMENTAL

Structured Directive Telephone Support Calls

Behavioral: Continuing Care Telephone Support

2

EXPERIMENTAL

Structured Non-Directive Telephone Continuing Care Support

Behavioral: Continuing Care Telephone Support

3

EXPERIMENTAL

Unstructured Directive Telephone Support

Behavioral: Continuing Care Telephone Support

4

EXPERIMENTAL

Unstructured Non-Directive Telephone Support

Behavioral: Continuing Care Telephone Support

5

NO INTERVENTION

Interventions

Continuing Care Telephone Support BEHAVIORAL

Counselor-provided telephone support as strategies to promote patient aftercare attendance and sustained abstinence from stimulant use. To this end, we will develop and compare the efficacy of four low-cost telephone support protocols for patients who have completed the intensive phase of a structured, outpatient stimulant abuse treatment program.

1; 2; 3; 4

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Males or females, 18-65 years of age.
• Meet DSM-IV criteria (at the time of treatment admission) for cocaine or methamphetamine abuse/dependence.
• Have completed the primary phase of treatment at a Matrix outpatient clinic.
• Have telephone access throughout the study procedures.
• Be able to understand and complete rating scales and to follow instructions.
• Be willing to sign an informed consent form.

You may not qualify if:

• Have participated in a treatment-related study conducted by the PI and colleagues during the previous 3 years and/or is currently enrolled in a treatment-related study.
• Have any medical, legal, housing or transportation problem which would preclude either safe or consistent participation.
• Have dropped out of the primary phase of treatment prior to completion.

Sponsors & Collaborators

• University of California, Los Angeles: lead
• National Institute on Drug Abuse (NIDA): collaborator

Study Sites (6)

Twin Town Treatment Center

Los Alamitos, California, 90720, United States

Location

Matrix Institute on Addictions

Los Angeles, California, 90025, United States

Location

UCLA Integrated Substance Abuse Programs

Los Angeles, California, 90025, United States

Location

Matrix Institute on Addictions

Rancho Cucamonga, California, 91730, United States

Location

Twin Town Treatment Center

West Hollywood, California, 90069, United States

Location

Matrix Institute on Addicitions

Woodland Hills, California, 91364, United States

Location

Related Publications (48)

• Ahles TA, Schlundt DG, Prue DM, Rychtarik RG. Impact of aftercare arrangements on the maintenance of treatment success in abusive drinkers. Addict Behav. 1983;8(1):53-8. doi: 10.1016/0306-4603(83)90056-4.

  PMID: 6308970 BACKGROUND

• Allen K. Barriers to treatment for addicted African-American women. J Natl Med Assoc. 1995 Oct;87(10):751-6.

  PMID: 7473850 BACKGROUND

• Ashery RS, Carlson RG, Falck RS, Siegal HA. Injection drug users, crack-cocaine users, and human services utilization: an exploratory study. Soc Work. 1995 Jan;40(1):75-82.

  PMID: 7863375 BACKGROUND

• Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986 Dec;51(6):1173-82. doi: 10.1037//0022-3514.51.6.1173.

  PMID: 3806354 BACKGROUND

• Battjes RJ, Onken LS, Delany PJ. Drug abuse treatment entry and engagement: report of a meeting on treatment readiness. J Clin Psychol. 1999 May;55(5):643-57. doi: 10.1002/(sici)1097-4679(199905)55:53.0.co;2-s.

  PMID: 10392794 BACKGROUND

• Brown BS, O'Grady KE, Battjes RJ, Farrell EE, Smith NP, Nurco DN. Effectiveness of a stand-alone aftercare program for drug-involved offenders. J Subst Abuse Treat. 2001 Dec;21(4):185-92. doi: 10.1016/s0740-5472(01)00201-x.

  PMID: 11777667 BACKGROUND

• Burton P, Gurrin L, Sly P. Extending the simple linear regression model to account for correlated responses: an introduction to generalized estimating equations and multi-level mixed modelling. Stat Med. 1998 Jun 15;17(11):1261-91. doi: 10.1002/(sici)1097-0258(19980615)17:113.0.co;2-z.

  PMID: 9670414 BACKGROUND

• De Leon G, Melnick G, Kressel D, Jainchill N. Circumstances, motivation, readiness, and suitability (the CMRS scales): predicting retention in therapeutic community treatment. Am J Drug Alcohol Abuse. 1994 Nov;20(4):495-515. doi: 10.3109/00952999409109186.

  PMID: 7832182 BACKGROUND

• De Leon G, Melnick G, Thomas G, Kressel D, Wexler HK. Motivation for treatment in a prison-based therapeutic community. Am J Drug Alcohol Abuse. 2000 Feb;26(1):33-46. doi: 10.1081/ada-100100589.

  PMID: 10718162 BACKGROUND

• Dees SM, Dansereau DF, Peel JL, Boatler JG, Knight K. Using conceptual matrices, knowledge maps, and scripted cooperation to improve personal management strategies. J Drug Educ. 1991;21(3):211-30. doi: 10.2190/KJKM-F0UR-RDPH-8NUK.

  PMID: 1919960 BACKGROUND

• Diez-Roux AV. Multilevel analysis in public health research. Annu Rev Public Health. 2000;21:171-92. doi: 10.1146/annurev.publhealth.21.1.171.

  PMID: 10884951 BACKGROUND

• Farabee D, Rawson R, McCann M. Adoption of drug avoidance activities among patients in contingency management and cognitive-behavioral treatments. J Subst Abuse Treat. 2002 Dec;23(4):343-50. doi: 10.1016/s0740-5472(02)00297-0.

  PMID: 12495796 BACKGROUND

• Fischer B, Chin AT, Kuo I, Kirst M, Vlahov D. Canadian illicit opiate users' views on methadone and other opiate prescription treatment: an exploratory qualitative study. Subst Use Misuse. 2002 Mar;37(4):495-522. doi: 10.1081/ja-120002807.

  PMID: 12064431 BACKGROUND

• Fitzgerald JL, Mulford HA. An experimental test of telephone aftercare contacts with alcoholics. J Stud Alcohol. 1985 Sep;46(5):418-24. doi: 10.15288/jsa.1985.46.418.

  PMID: 2999514 BACKGROUND

• Fortney JC, Booth BM, Blow FC, Bunn JY. The effects of travel barriers and age on the utilization of alcoholism treatment aftercare. Am J Drug Alcohol Abuse. 1995 Aug;21(3):391-406. doi: 10.3109/00952999509002705.

  PMID: 7484987 BACKGROUND

• Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment: clinical applications. JAMA. 2002 Dec 11;288(22):2880-3. doi: 10.1001/jama.288.22.2880.

  PMID: 12472330 BACKGROUND

• Huber A, Lord RH, Gulati V, Marinelli-Casey P, Rawson R, Ling W. The CSAT methamphetamine treatment program: research design accommodations for "real world" application. J Psychoactive Drugs. 2000 Apr-Jun;32(2):149-56. doi: 10.1080/02791072.2000.10400223.

  PMID: 10908002 BACKGROUND

• Huber A, Ling W, Shoptaw S, Gulati V, Brethen P, Rawson R. Integrating treatments for methamphetamine abuse: a psychosocial perspective. J Addict Dis. 1997;16(4):41-50. doi: 10.1080/10550889709511142.

  PMID: 9328808 BACKGROUND

• Hunt WA, Barnett LW, Branch LG. Relapse rates in addiction programs. J Clin Psychol. 1971 Oct;27(4):455-6. doi: 10.1002/1097-4679(197110)27:43.0.co;2-r. No abstract available.

  PMID: 5115648 BACKGROUND

• Hser YI, Anglin D, Powers K. A 24-year follow-up of California narcotics addicts. Arch Gen Psychiatry. 1993 Jul;50(7):577-84. doi: 10.1001/archpsyc.1993.01820190079008.

  PMID: 8317951 BACKGROUND

• Hser YI, Hoffman V, Grella CE, Anglin MD. A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry. 2001 May;58(5):503-8. doi: 10.1001/archpsyc.58.5.503.

  PMID: 11343531 BACKGROUND

• Iguchi MY, Belding MA, Morral AR, Lamb RJ, Husband SD. Reinforcing operants other than abstinence in drug abuse treatment: an effective alternative for reducing drug use. J Consult Clin Psychol. 1997 Jun;65(3):421-8. doi: 10.1037//0022-006x.65.3.421.

  PMID: 9170765 BACKGROUND

• Intagliata J. A telephone follow-up procedure for increasing the effectiveness of a treatment program for alcoholics. J Stud Alcohol. 1976 Sep;37(9):1330-5. doi: 10.15288/jsa.1976.37.1330.

  PMID: 185468 BACKGROUND

• Karno MP, Beutler LE, Harwood TM. Interactions between psychotherapy procedures and patient attributes that predict alcohol treatment effectiveness: a preliminary report. Addict Behav. 2002 Sep-Oct;27(5):779-97. doi: 10.1016/s0306-4603(01)00209-x.

  PMID: 12201384 BACKGROUND

• Koumans AJ, Muller JJ, Miller CF. Use of telephone calls to increase motivation for treatment in alcoholics. Psychol Rep. 1967 Aug;21(1):327-8. doi: 10.2466/pr0.1967.21.1.327. No abstract available.

  PMID: 6078383 BACKGROUND

• Lash SJ, Blosser SL. Increasing adherence to substance abuse aftercare group therapy. J Subst Abuse Treat. 1999 Jan;16(1):55-60. doi: 10.1016/s0740-5472(98)00015-4.

  PMID: 9888122 BACKGROUND

• Lash SJ, Dillard W. Encouraging participation in aftercare group therapy among substance-dependent men. Psychol Rep. 1996 Oct;79(2):585-6. doi: 10.2466/pr0.1996.79.2.585.

  PMID: 8909084 BACKGROUND

• Lovejoy M, Rosenblum A, Magura S, Foote J, Handelsman L, Stimmel B. Patients' perspective on the process of change in substance abuse treatment. J Subst Abuse Treat. 1995 Jul-Aug;12(4):269-82. doi: 10.1016/0740-5472(95)00027-3.

  PMID: 8830154 BACKGROUND

• MacKinnon DP, Lockwood CM, Hoffman JM, West SG, Sheets V. A comparison of methods to test mediation and other intervening variable effects. Psychol Methods. 2002 Mar;7(1):83-104. doi: 10.1037/1082-989x.7.1.83.

  PMID: 11928892 BACKGROUND

• McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA. 2002 Dec 11;288(22):2868-79. doi: 10.1001/jama.288.22.2868.

  PMID: 12472329 BACKGROUND

• McKay JR. Effectiveness of continuing care interventions for substance abusers. Implications for the study of long-term treatment effects. Eval Rev. 2001 Apr;25(2):211-32. doi: 10.1177/0193841X0102500205.

  PMID: 11317717 BACKGROUND

• McKay JR, McLellan AT, Alterman AI, Cacciola JS, Rutherford MJ, O'Brien CP. Predictors of participation in aftercare sessions and self-help groups following completion of intensive outpatient treatment for substance abuse. J Stud Alcohol. 1998 Mar;59(2):152-62. doi: 10.15288/jsa.1998.59.152.

  PMID: 9500302 BACKGROUND

• Pan W. Sample size and power calculations with correlated binary data. Control Clin Trials. 2001 Jun;22(3):211-27. doi: 10.1016/s0197-2456(01)00131-3.

  PMID: 11384786 BACKGROUND

• Peterson KA, Swindle RW, Phibbs CS, Recine B, Moos RH. Determinants of readmission following inpatient substance abuse treatment: a national study of VA programs. Med Care. 1994 Jun;32(6):535-50. doi: 10.1097/00005650-199406000-00001.

  PMID: 8189773 BACKGROUND

• Ouimette PC, Moos RH, Finney JW. Influence of outpatient treatment and 12-step group involvement on one-year substance abuse treatment outcomes. J Stud Alcohol. 1998 Sep;59(5):513-22. doi: 10.15288/jsa.1998.59.513.

  PMID: 9718103 BACKGROUND

• Rawson RA, Shoptaw SJ, Obert JL, McCann MJ, Hasson AL, Marinelli-Casey PJ, Brethen PR, Ling W. An intensive outpatient approach for cocaine abuse treatment. The Matrix model. J Subst Abuse Treat. 1995 Mar-Apr;12(2):117-27. doi: 10.1016/0740-5472(94)00080-b.

  PMID: 7623389 BACKGROUND

• Rawson RA, Marinelli-Casey P, Anglin MD, Dickow A, Frazier Y, Gallagher C, Galloway GP, Herrell J, Huber A, McCann MJ, Obert J, Pennell S, Reiber C, Vandersloot D, Zweben J; Methamphetamine Treatment Project Corporate Authors. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction. 2004 Jun;99(6):708-17. doi: 10.1111/j.1360-0443.2004.00707.x.

  PMID: 15139869 BACKGROUND

• Rawson RA, Obert JL, McCann MJ, Ling W. Neurobehavioral treatment for cocaine dependency: a preliminary evaluation. NIDA Res Monogr. 1993;135:92-115.

  PMID: 8289906 BACKGROUND

• Richter KP, Bammer G. A hierarchy of strategies heroin-using mothers employ to reduce harm to their children. J Subst Abuse Treat. 2000 Dec;19(4):403-13. doi: 10.1016/s0740-5472(00)00137-9.

  PMID: 11166505 BACKGROUND

• Rochon J. Application of GEE procedures for sample size calculations in repeated measures experiments. Stat Med. 1998 Jul 30;17(14):1643-58. doi: 10.1002/(sici)1097-0258(19980730)17:143.0.co;2-3.

  PMID: 9699236 BACKGROUND

• Shoptaw S, Rawson RA, McCann MJ, Obert JL. The Matrix model of outpatient stimulant abuse treatment: evidence of efficacy. J Addict Dis. 1994;13(4):129-41. doi: 10.1300/j069v13n04_02.

  PMID: 7734464 BACKGROUND

• Shrout PE, Bolger N. Mediation in experimental and nonexperimental studies: new procedures and recommendations. Psychol Methods. 2002 Dec;7(4):422-45.

  PMID: 12530702 BACKGROUND

• Silverman K, Higgins ST, Brooner RK, Montoya ID, Cone EJ, Schuster CR, Preston KL. Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy. Arch Gen Psychiatry. 1996 May;53(5):409-15. doi: 10.1001/archpsyc.1996.01830050045007.

  PMID: 8624184 BACKGROUND

• Sobell LC, Maisto SA, Sobell MB, Cooper AM. Reliability of alcohol abusers' self-reports of drinking behavior. Behav Res Ther. 1979;17(2):157-60. doi: 10.1016/0005-7967(79)90025-1. No abstract available.

  PMID: 426744 BACKGROUND

• Spitzer RL, Williams JB, Gibbon M, First MB. The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry. 1992 Aug;49(8):624-9. doi: 10.1001/archpsyc.1992.01820080032005.

  PMID: 1637252 BACKGROUND

• Stahler GJ, Cohen E. Using ethnographic methodology in substance abuse treatment outcome research. J Subst Abuse Treat. 2000 Jan;18(1):1-8. doi: 10.1016/s0740-5472(99)00029-x.

  PMID: 10636600 BACKGROUND

• Stout RL, Wirtz PW, Carbonari JP, Del Boca FK. Ensuring balanced distribution of prognostic factors in treatment outcome research. J Stud Alcohol Suppl. 1994 Dec;12:70-5. doi: 10.15288/jsas.1994.s12.70.

  PMID: 7723001 BACKGROUND

• Farabee D, Cousins SJ, Brecht ML, Antonini VP, Lee AB, Brummer J, Hemberg J, Karno M, Rawson RA. A comparison of four telephone-based counseling styles for recovering stimulant users. Psychol Addict Behav. 2013 Mar;27(1):223-9. doi: 10.1037/a0029572. Epub 2012 Aug 6.

  PMID: 22867295 RESULT

Related Links

• Related Info

MeSH Terms

Conditions

Substance-Related Disorders

Condition Hierarchy (Ancestors)

Chemically-Induced Disorders; Mental Disorders

Study Officials

• David Farabee, Ph.D.

  UCLA Integrated Substance Abuse Programs

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 28, 2008
• First Posted: August 29, 2008
• Study Start: April 1, 2006
• Primary Completion: September 1, 2010
• Study Completion: September 1, 2011
• Last Updated: November 28, 2016

Record last verified: 2016-11

Locations

US (6)